the prospect of no periods with Lybrel, the first oral contraceptive approved for CONTINUOUS use

July 2007

Women are excited about the prospect of no periods with Lybrel, the first oral contraceptive approved for CONTINUOUS use.

It contains ethinyl estradiol 20 mcg and levonorgestrel 90 mcg. Women take active pills EVERY day for a year or longer.

This means no scheduled periods...and possibly a lower incidence of PMS, headaches, and anemia.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote